MarketCap
Facebook
X
TelegramAnnual report 2025
added 04-18-2026
QIAGEN N.V. Total Inventories 2011-2026 | QGEN
Annual Total Inventories QIAGEN N.V.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 302 M | 279 M | 398 M | 358 M | 328 M | 291 M | 171 M | 163 M | 156 M | 137 M | 137 M | 132 M | 128 M | 135 M | 132 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 398 M | 128 M | 216 M |
Quarterly Total Inventories QIAGEN N.V.
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 328 M | - | - | - | 291 M | - | - | - | 171 M | - | - | - | 163 M | - | - | - | 156 M | - | - | - | 137 M | - | - | - | 137 M | - | - | - | 132 M | - | - | - | 128 M | - | - | - | 135 M | - | - | - | 132 M | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 328 M | 128 M | 174 M |
Total Inventories of other stocks in the Diagnostics research industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Agilent Technologies
A
|
830 M | $ 111.3 | -3.12 % | $ 33.8 B |  USA |
 |
Biocept
BIOC
|
757 K | - | -13.05 % | $ 7.29 M | USA |
 |
Aspira Women's Health
AWH
|
256 K | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
5.19 M | - | -61.36 % | $ 2.46 M | USA |
 |
CareDx, Inc
CDNA
|
26.7 M | $ 20.8 | -5.07 % | $ 1.11 B | USA |
 |
Chembio Diagnostics
CEMI
|
7.72 M | - | 0.22 % | $ 16.8 M | USA |
 |
Co-Diagnostics
CODX
|
992 K | $ 1.53 | -6.13 % | $ 2.04 M | USA |
 |
Castle Biosciences
CSTL
|
8.14 M | $ 24.24 | -1.86 % | $ 673 M | USA |
 |
DermTech
DMTK
|
1 M | - | -11.32 % | $ 2.94 M | USA |
 |
Global Cord Blood Corporation
CO
|
45.9 M | - | - | $ 399 M |  China |
 |
Charles River Laboratories International
CRL
|
299 M | $ 163.84 | -1.77 % | $ 8.12 B | USA |
 |
Enzo Biochem
ENZ
|
6.83 M | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
166 M | - | - | $ 19.8 B | USA |
 |
Guardant Health
GH
|
85.9 M | $ 83.41 | 0.35 % | $ 10.5 B | USA |
 |
Heska Corporation
HSKA
|
60 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
909 K | - | -20.0 % | $ 1.06 M | USA |
 |
Interpace Biosciences
IDXG
|
1.11 M | $ 1.99 | 2.9 % | $ 8.8 M | USA |
 |
Illumina
ILMN
|
547 M | $ 120.37 | -5.16 % | $ 19.1 B | USA |
 |
Biomerica
BMRA
|
1.49 M | $ 2.16 | -1.22 % | $ 4.96 M | USA |
 |
Lantheus Holdings
LNTH
|
64.7 M | $ 81.17 | -2.85 % | $ 5.48 B | USA |
 |
ICON Public Limited Company
ICLR
|
2.3 M | $ 116.17 | 13.35 % | $ 9.58 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
535 M | $ 257.14 | -0.94 % | $ 21.4 B | USA |
 |
Motus GI Holdings
MOTS
|
496 K | - | -34.28 % | $ 263 K |  Israel |
 |
NeoGenomics
NEO
|
28.6 M | $ 8.96 | -0.67 % | $ 1.15 B | USA |
 |
Neogen Corporation
NEOG
|
191 M | $ 9.01 | -3.53 % | $ 1.95 B | USA |
 |
Invitae Corporation
NVTA
|
30.4 M | - | - | $ 21.2 M | USA |
 |
Myriad Genetics
MYGN
|
30.6 M | $ 4.68 | -3.31 % | $ 433 M | USA |
 |
OpGen
OPGN
|
3.65 M | - | -16.95 % | $ 1.54 M | USA |
 |
Natera
NTRA
|
35.4 M | $ 194.75 | -2.71 % | $ 19.2 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
189 M | $ 189.32 | -2.94 % | $ 21 B | USA |
 |
Burning Rock Biotech Limited
BNR
|
123 M | $ 16.24 | -2.46 % | $ 175 M | China |
 |
Organovo Holdings
ONVO
|
297 K | - | -2.3 % | $ 19.4 M | USA |
 |
PerkinElmer
PKI
|
379 M | - | -0.91 % | $ 14.7 B | USA |
 |
Precipio
PRPO
|
935 K | $ 29.94 | -5.73 % | $ 48.1 M | USA |